🏛️ Verified NIH Record • Updated 2026-08-12
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy (NCT06309966)
A Phase 2/3 Multicenter, Randomization, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV-7000 in Subjects With Refractory Focal Onset Epilepsy
🔵 Active, Not Recruiting Phase2 / Phase3 💊 Investigational Drug / Biologic Sponsor: Biohaven Therapeutics Ltd.
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
Who can join: Review the eligibility criteria below.
Location: Onyx Clinical Trials — Peoria, Arizona
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (150 Sites)
Showing the first 25 of 150 sites.
- Onyx Clinical Trials — Peoria, Arizona
- Xenoscience, Inc. — Phoenix, Arizona
- University of Arizona / Banner University Medical Center Phoenix — Phoenix, Arizona
- ARENSIA Exploratory Medicine — Phoenix, Arizona
- Clinical Trials, Inc. — Little Rock, Arkansas
- Tri Valley Neurology Medical Associates, Inc. — Mission Hills, California
- Profound Research LLC — Poway, California
- UConn Health — Farmington, Connecticut
- Nova Clinical Research, LLC — Bradenton, Florida
- Las Mercedes Medical Research — Hialeah, Florida
- Coral Clinic Research — Homestead, Florida
- Y&L Advance Health Care, Inc d/b/a Elite Clinical Research — Miami, Florida
- Serenity Research Center — Miami, Florida
- Research Institute of Orlando — Orlando, Florida
- Comprehensive Neurology Clinic — Orlando, Florida
- Panhandle Research & Medical Clinic — Pensacola, Florida
- Knight Neurology — Rockledge, Florida
- Encore Medical Research of Weston LLC. — Weston, Florida
- Accelerated Clinical Trials, LLC — Peachtree Corners, Georgia
- Bluegrass Epilepsy Research — Lexington, Kentucky
- DelRicht Research — Baton Rouge, Louisiana
- Neurocare Of Louisiana — Covington, Louisiana
- University Medical Center New Orleans — New Orleans, Louisiana
- DelRicht Research — New Orleans, Louisiana
- LSU Health Shreveport — Shreveport, Louisiana
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Focal Epilepsy
- A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy — Birmingham, Alabama
- Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures — Miami, Florida
- Breathing Rescue for SUDEP Prevention — Houston, Texas
- A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures — Boise, Idaho
- Study of Transcranial Direct Current Stimulation to Treat Epilepsy — Rochester, Minnesota
Explore by condition: All Focal Epilepsy clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.